Pfizer COVID Pill Becomes First At-Home Treatment Authorized by U.S.

Controversial Hydroxychloroquine Is Being Suggested As a Potential Medication That Could Cure the Coronavirus (COVID - 19) Pandemic

Photo: Getty Images

On Wednesday, United States health regulators approved Pfizer's pill to fight COVID as the first at-home treatment in the U.S.

Patients that are suffering from COVID-19 will be able to take home these pills and hopefully fight off some of the symptoms felt due to the virus.

Paxlovid is a fast and cheap way to fight the COVID-19 infection. The new Pfizer pill is said to have mild side effects and very high effectiveness against the virus. This is a game-changer.

Dr. Gregory Poland of the Mayo Clinic discussed the new Pfizer pill, he said:

“The efficacy is high, the side effects are low and it’s oral. It checks all the boxes,”

he continued:

“You’re looking at a 90% decreased risk of hospitalization and death in a high-risk group — that’s stunning.”

The Pfizer pill is authorized by FDA for adults and children over the age of 12 - they must have a positive COVID diagnosis and early symptoms.

Merck is also expected to receive authorization for their pill that will also combat COVID-19.

Both the Pfizer and Merck COVID pills are expected to fight against the Omicron variant as both pills don't target the spike protein of the virus, where the variant's mutations reside.

The United States Government expects to treat over 10 million people with the Paxlovid medication as they agreed to purchase enough to treat 10 million. Pfizer has also said that they plan on producing 80 million units in the coming year.

Patients that will be using this medication will be required to show a positive COVID test, in order to obtain a prescription for the medication. It is also worth noting that Paxlovid is only effective if prescribed and given within five days of symptoms appearing.

Sponsored Content

Sponsored Content